Funding-round
CinDome Pharma - series b extension
| Company | CinDome Pharma |
|---|---|
| Amount | $40,000,000 |
| Currency | USD |
| Announcement date | 2024-05-16 |
| Round type | series b extension |
| Primary source url | https://www.finsmes.com/2024/05/cindome-pharma-raises-40m-in-series-b-extension.html |
| Terms or valuation | The company intends to use the funds for the ongoing enrollment and evaluation of deudomperidone in the Phase 2 envision3D study in adults with diabetic gastroparesis and position itself for registrational trials |
Participating investors
| Company | Lead |
|---|---|
| Perceptive Advisors | |
| CinRx Pharma |